MEDIPOST Co., Ltd.
PublicMEDIPOST Co., Ltd. is now publicly traded
The data on this page reflects MEDIPOST Co., Ltd.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Early Funding
Jan 9, 2026
Total Funding Raised
$140M
Company Overview
MEDIPOST Co., Ltd. is a biotechnology company that develops and commercializes allogeneic, umbilical cord blood-derived stem cell therapies for inflammation-driven and degenerative diseases.
AI Layer
Non-AI
Keywords
MEDIPOST Co., Ltd. Comparables
Compare MEDIPOST Co., Ltd. with similar companies based on industry and business-model similarity.
No public comparables are available for MEDIPOST Co., Ltd.. Request access to learn about comparables coverage.
Request accessMEDIPOST Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jan 9, 2026 |
MEDIPOST Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Crescendo Equity Partners | Early Funding |
MEDIPOST Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access